• Life sciences M&A update: H1-2017

    Baker Tilly Capital, LLC's life sciences M&A newsletter provides an overview of the U.S. medical devices and products, pharmaceutical (pharma) and pharma outsourced services sectors, including recent performance and M&A trends.
  • Healthcare M&A update: Q2-2017

    The second quarter of 2017 showed positive performance for the broader U.S. equity market, as the S&P, DJIA and NASDAQ closed up 2.6 percent, 3.3 percent and 3.9 percent, respectively, for the quarter.
  • Great Lakes regional M&A update: Q2-2017

    Middle-market M&A transactions in the Great Lakes region experienced a decrease in the total amount of deal volume, but an increase in aggregate deal value during the second quarter of 2017.
  • Philadelphia regional M&A update: Q2-2017

    There were 143 transactions that closed in the Philadelphia regional market during the second quarter of 2017, a decline of 2.1 percent from the 146 closed transactions in the prior quarter (Q1-2017).